Infliximab-associated fulminant hepatic failure in ulcerative colitis: a case report

INTRODUCTION: Infliximab, an antibody against tumor necrosis factor alpha, is used to treat inflammatory bowel disease and has well-established efficacy and proven safety. Complications of this treatment are related to immunosuppression and include higher risk of serious infections and malignant neo...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Med Case Rep
Hlavní autoři: Parra, Rogerio Serafim, Feitosa, Marley Ribeiro, Machado, Vanessa Foresto, Ramalho, Leandra Naira Zambelli, Rocha, Jose Joaquim Ribeiro da, Feres, Omar
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2015
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4627392/
https://ncbi.nlm.nih.gov/pubmed/26518665
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-015-0730-5
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky